Detailed Information on Publication Record
2011
Adipsin (Complement Factor D) As a New Biomarker of Body Fat Distribution in Extremely Obese Central-European Population
BIENERTOVÁ VAŠKŮ, Julie, Petr BIENERT, Filip ZLÁMAL, Josef TOMANDL, Martin FOREJT et. al.Basic information
Original name
Adipsin (Complement Factor D) As a New Biomarker of Body Fat Distribution in Extremely Obese Central-European Population
Name in Czech
Adipsin (komplementový faktor D) jako nový biomarker distribuce tělesného tuku u extrémně obézní české populace
Authors
BIENERTOVÁ VAŠKŮ, Julie (203 Czech Republic, guarantor, belonging to the institution), Petr BIENERT (203 Czech Republic, belonging to the institution), Filip ZLÁMAL (203 Czech Republic, belonging to the institution), Josef TOMANDL (203 Czech Republic, belonging to the institution), Martin FOREJT (203 Czech Republic, belonging to the institution), Zlata PISKÁČKOVÁ (203 Czech Republic, belonging to the institution), Martin VAVŘINA (203 Czech Republic, belonging to the institution), Jana KUDĚLKOVÁ (203 Czech Republic, belonging to the institution) and Anna VAŠKŮ (203 Czech Republic, belonging to the institution)
Edition
1. vyd. New York, Body Fat: Composition, Measurements and Reduction Procedures, p. 14-27, 13 pp. Body Fat: Composition, Measurements and Reduction, 2011
Publisher
Novapublishers
Other information
Language
English
Type of outcome
Kapitola resp. kapitoly v odborné knize
Field of Study
30202 Endocrinology and metabolism
Country of publisher
United States of America
Confidentiality degree
není předmětem státního či obchodního tajemství
RIV identification code
RIV/00216224:14110/11:00052327
Organization unit
Faculty of Medicine
ISBN
978-1-61324-332-9
Keywords (in Czech)
adipsin; morbidní obezita; distribuce tělesného tuku
Keywords in English
adipsin; morbid obesity; body fat distribution
Změněno: 3/2/2012 10:34, Mgr. Michal Petr
V originále
In this study, we identified strong positive correlations of adipsin plasma concentration with parameters of body fat distribution in extremely obese Central-European population, such as percentage of body fat and waist circumference, both considered important negative risk factors for obesity-associated comorbidities. More research is required to provide a better insight into the role of adipsin in obesity development to elucidate the underlying pathophysiological mechanisms of observed correlations.
In Czech
V této studii podáváme důkazy o silné závislosti hladin adipsinu na celkovém % tukové tkáně u morbidně obézní české populace.